Close
Enter your
text here

Division of Hematology Oncology and Bone Marrow Transplant (BMT)

Featured Researcher – Ruoning Wang, PhD
 Featured Researcher – Ruoning Wang, PhD 150 150 Alaina Doklovic
By: Alaina Doklovic

Ruoning Wang, PhD, is a principal investigator in the Center for Childhood Cancer for the Abigail Wexner Research Institute (AWRI) at Nationwide Children’s Hospital, a principal investigator for the Division of Hematology and Oncology at Nationwide Children’s Hospital and a professor in the Department of Pediatrics at The Ohio State University College of Medicine. Dr.…

Improving Medication Adherence and Clinical Outcomes After Hematopoietic Stem Cell Transplant
 Improving Medication Adherence and Clinical Outcomes After Hematopoietic Stem Cell Transplant 1024 683 JoAnna Pendergrass, DVM
By: JoAnna Pendergrass, DVM

A clinical trial is evaluating the acceptability and efficacy of a mobile app in improving medication adherence, symptoms and clinical outcomes in pediatric hematopoietic stem cell patients. A research team led by Micah Skeens, PhD, APRN, FAAN, principal investigator in the Center for Biobehavioral Health at the Abigail Wexner Research Institute, assistant professor of pediatrics…

Changing the Landscape of Blood Disorder Treatments: A Long Time Coming
 Changing the Landscape of Blood Disorder Treatments: A Long Time Coming 1024 574 Alaina Doklovic
By: Alaina Doklovic

New therapies, from virus-mediated gene therapy to CRISPR-based treatments, are poised to change the clinical landscape of blood disorder treatments and outcomes.   For more than two decades experts have been searching for curative therapies for blood disorders. They have invested time, money and expertise to bring these therapies to fruition, something that the Division…

Transforming Treatment for Paratesticular Rhabdomyosarcoma in Adolescents through Robotics
 Transforming Treatment for Paratesticular Rhabdomyosarcoma in Adolescents through Robotics 1024 683 Erin Gregory
By: Erin Gregory

Retroperitoneal lymph node dissection (RPLND) has been a crucial component of treating testicular and paratesticular cancers for over a century. Recent advancements in minimally invasive techniques, such as robotic-assisted methods, have expanded the applicability of RPLND, offering reduced morbidity and faster recovery. However, concerns persist regarding the equivalence of oncological outcomes compared to traditional open…